Skip to main content
NUS
NYSE Trade & Services

Nu Skin Reports Significant Q1 Revenue and EPS Decline, Maintains Negative Full-Year Outlook

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
8
Price
$6.8
Mkt Cap
$345.221M
52W Low
$5.65
52W High
$14.62
Market data snapshot near publication time

summarizeSummary

Nu Skin Enterprises announced Q1 2026 financial results showing a 12% revenue decline and a significant drop in EPS year-over-year, alongside decreases in customer and sales leader counts. The company maintained its full-year guidance, which anticipates further revenue contraction.


check_boxKey Events

  • Q1 Revenue Misses Prior Year

    First quarter 2026 revenue was $320.6 million, a 12.0% decrease compared to $364.5 million in the prior-year quarter, though it was within the company's guidance range.

  • EPS Declines Significantly

    Diluted GAAP EPS for Q1 2026 was $0.04, down from $2.14 in Q1 2025. Adjusted EPS also fell to $0.14 from $0.23, excluding certain charges and a one-time gain from a prior-year sale.

  • Operational Metrics Show Contraction

    Customer count decreased by 14% to 669,535, paid affiliates by 8% to 120,850, and sales leaders by 13% to 26,915, indicating a shrinking sales force and customer base.

  • Full-Year Guidance Maintained with Negative Outlook

    The company maintained its full-year 2026 revenue guidance of $1.35 billion to $1.50 billion (a 9% to 1% decline year-over-year) and adjusted EPS guidance of $0.80 to $1.20, reflecting continued challenges.


auto_awesomeAnalysis

Nu Skin Enterprises reported a challenging first quarter with substantial year-over-year declines in revenue, earnings per share, and key operational metrics including customers, paid affiliates, and sales leaders. While Q1 revenue was within the company's guidance range, the overall trend indicates ongoing business contraction. The company reiterated its full-year 2026 guidance, which projects continued revenue decline, signaling a persistent challenging environment. Management highlighted efforts to scale its new intelligent wellness platform and expand into emerging markets, but acknowledged these initiatives will take time to impact results. The significant drop in core business metrics and the maintained negative outlook suggest continued headwinds for the company.

At the time of this filing, NUS was trading at $6.80 on NYSE in the Trade & Services sector, with a market capitalization of approximately $345.2M. The 52-week trading range was $5.65 to $14.62. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed NUS - Latest Insights

NUS
May 08, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
NUS
May 07, 2026, 8:04 PM EDT
Filing Type: 10-Q
Importance Score:
9
NUS
May 07, 2026, 5:09 PM EDT
Filing Type: 8-K
Importance Score:
8
NUS
May 07, 2026, 4:07 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
NUS
Apr 03, 2026, 2:28 PM EDT
Filing Type: DEF 14A
Importance Score:
8
NUS
Mar 27, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
8
NUS
Mar 27, 2026, 4:34 PM EDT
Filing Type: 8-K
Importance Score:
8
NUS
Mar 20, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
7
NUS
Mar 09, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
NUS
Feb 12, 2026, 9:49 PM EST
Filing Type: 10-K
Importance Score:
7